Nano-X Imaging reported its second-quarter earnings on September 9, with revenue up 37% year-over-year to $4.2 million, primarily driven by the integration of its Nanox Health IT business. However, the company recorded an impairment charge of $40.7 million, leading to a GAAP gross margin of -1051% and a net loss of $55.5 million. As of June 30, the company's cash reserves had decreased to $31.4 million from $60 million at the end of 2025, with CFO Guy Nathanzon stating that the company's resources raise substantial doubt about its ability to continue as a going concern. To address cash consumption, the company plans to restructure its operations, including outsourcing chip manufacturing and reducing its workforce (67% reduction at its South Korean factory and 15% in Israel), which is expected to save $2 million annually starting in 2027.